ArticleBMC methods2026
A simple and versatile fluorescence-based method to enhance prime editing in human pluripotent stem cells.
Article in BMC methods, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Background: Prime editing is a versatile and precise genome-editing technique that enables targeted modifications with unprecedented accuracy. Unlike other CRISPR-based methods, prime editing does not induce double-stranded DNA breaks, thereby minimizing genomic instability and off-target effects. This technology allows for precise insertions, deletions, and substitutions, surpassing the limitations of conventional genome-editing approaches. However, a major challenge remains-low editing efficiency in human pluripotent stem cells (hPSCs), which restricts its broader application in stem cell research and regenerative medicine. Methods: This protocol describes Prime-Induced Nucleotide Engineering using a Transient Reporter for Editing Enrichment (PINE-TREE), a fluorescence-based system designed to enhance prime editing efficiency in hPSCs. The step-by-step methodology details plasmid construction, transfection, and clonal isolation strategies, facilitating real-time enrichment of prime-edited cells. Additionally, the protocol includes comprehensive methods for evaluating off-target effects and confirming the maintenance of pluripotency, ensuring precision and reliability in edited cell lines. Discussion: PINE-TREE significantly improves the efficiency of prime editing in hPSCs, addressing key limitations associated with low editing rates. By enabling real-time fluorescence-based enrichment, this system enhances the isolation of successfully edited cells, reducing the need for labor-intensive selection processes. Moreover, its adaptability across multiple cell types and compatibility with various prime editing strategies make it a valuable tool for researchers in genome engineering, disease modeling, and regenerative medicine. Clinical trial number: Not applicable.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.